Impact of sodium-glucose co-transporter inhibitors in mortality and decongestion in cardiac amyloidosis: A systematic review and meta-analysis

1 September 2025 (13:15 - 14:00)
Organised by: Logo
Congress Presentation Part of: Myocardial disease and valvular heart disease: miscellany Pharmacotherapy ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

ESC 365 is supported by

ESC 365 is supported by